[Summary] 专注小分子创新靶向药研发
壹瑞医药成立于2018年,是一家专注小分子创新靶向药研发的Biotech企业,致力于通过科学立项、低成本、高效率、有效风控等研发策略进行源头创新。公司以自主研发为主导,适应症覆盖自身免疫性疾病、糖尿病并发症、慢性炎症性疾病等领域。在药物靶点、适应症选择、给药方式以及治疗人群等方面均开展差异化布局,努力为全球数亿患者未被满足的临床需求提供新的一线用药。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows